A new study from theMUSC Hollings Cancer Center has shown a potential connection between the HPV vaccination and cervical cancer deaths.In their study they no ...

In the 2023-24 period, 5.12 million individuals aged 25 to 64 in England were due a test and invited to book an appointment.

The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled study to determine the relative efficacy, safety, and immunogenicity of Vaxart’s oral pill COVID-19 vaccine ...

Vaccination of 27- to 45-year-olds against HPV is less cost-effective than vaccination of younger persons (aged 9 to 26 years).

A new study provides good evidence that the human papillomavirus (HPV) vaccine may be achieving its goal of slashing rates of ...

Robert F. Kennedy Jr., President-elect Donald Trump’s pick to oversee the nation’s health system, worries the medical ...

Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight ...

In the vibrant streets of Nairobi, a silent health crisis is unfolding, casting a shadow over the lives of gay, bisexual, and ...

Gen Z is largely ready for an inter-generational truce to take place. And now for the hard-hitting question: Are you?

For too long, men's health has been sidelined in the HIV response, leading to missed opportunities for early intervention and ...

While the HPV vaccine is often marketed in Iowa toward women, a health care professional says it’s important that young ...